April 6 (Reuters) - Organogenesis Holdings Inc ORGO.O:
ORGANOGENESIS ANNOUNCES SUCCESSFUL FDA MEETING AND PLAN TO FILE BLA FOR RENU® FOR KNEE OSTEOARTHRITIS PAIN
ORGANOGENESIS HOLDINGS INC - TO INITIATE ROLLING BLA FOR RENU FOLLOWING SUCCESSFUL FDA MEETING
ORGANOGENESIS HOLDINGS INC - BLA SUBMISSION FOR RENU EXPECTED BY END OF 2025
ORGANOGENESIS HOLDINGS INC: TO INITIATE A ROLLING BIOLOGICS LICENSES APPLICATION (BLA) FOR RENU PLANNED BEFORE END OF DECEMBER